5-((7-CHLORO-1H-INDOL-3-YL)METHYLENE)IMIDAZOLIDINE-2,4-DIONE, 95%, 10g

(3R)-3-fluoropyrrolidin-2-one, 98%, 250mg

2-Chloro-4-methylphenylisocyanate, 95.0%, 1g

Capillary pipettes without heparinization, 60 µl, 1000 pieces

3-Bromoimidazo[1,2-a]pyridin-7-amine, 95.0%, 500mg

2-(4-FLUOROPHENYL)-1-(PIPERIDIN-1-YL)ETHANONE, 95.0%, 2g

Ethyl 2-Ethylbutyrate>99.0%(GC)25mL

Magnesium sulphate heptahydrate, min. 99%, pa, ACS, 2.5 kg, plastic packaging.

7-Fluoro-1H-indazole-4-carboxylic acid, 97%, 25g

6-(3-(Trifluoromethoxy)phenyl)nicotinaldehyde, 97%, 1g

6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide, 99+%, 250mg

2-Fluoropyridine-3-boronic acid, 97.0%, 100g

BETA-OXO-CYCLOPENTANEPENTANOIC ACID ETHYL ESTER, 95.0%, 1g